The Scope of Mendelian Cardiomyopaties Genes

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The review is devoted to the analysis of the scope of the genes of Mendelian cardiomyopathies (CM), specifically hypertrophic, dilatational, arrhythmogenic, and restrictive cardiomyopathy. According to Simple ClinVar, pathogenic/probably pathogenic variants of 75 genes lead to the development of one or more types of CM. At the same time, these genes are characterized by their expression in various tissues and organs (not only in the heart and blood vessels, but also in various parts of the brain, gastrointestinal tract, etc.), as well as by their involvement in a variety of metabolic pathways and biological processes. These data are generally consistent with the results of genome-wide association studies (GWAS). Polymorphisms of the CM genes are associated with various types of CM and other cardiovascular diseases, as well as obesity, various diseases of the musculoskeletal and nervous systems, mental, oncological, infectious diseases, and others. In addition to pathological conditions, common variants of the CM genes contributed to the variability of a wide range of quantitative traits, including pathogenetically significant for various multifactorial diseases. The non-randomness of the identified associations of CM genes with a wide range of diseases is evidenced by: comorbidity of CM with GWAS-associated diseases or the involvement of the latter as a symptom, a risk factor for the development of myocardial pathology, a modifier of the clinical presentation; overlapping of the affected organ systems and the spectrum of pathologies associated with common variants (according to GWAS) and to which rare pathogenic variants (according to OMIM) of the CM genes lead; confirmation of the involvement of CM genes in the pathogenesis of pathologies of other organ systems at the molecular level. Thus, the data presented in the review indicate the wide scope of the genes of primary CM, which goes beyond the cardiovascular system. That indicates the relevance of conducting comprehensive studies aimed at determining the cause-and-effect relationships between the CM and pathologies of other organs, including with the involvement of molecular genetic data.

Full Text

Restricted Access

About the authors

A. N. Kucher

Research Institute of Medical Genetics, Federal State Budgetary Scientific Institution “Tomsk National Research Medical Center of the Russian Academy of Sciences”

Author for correspondence.
Email: maria.nazarenko@medgenetics.ru
Russian Federation, Tomsk

M. S. Nazarenko

Research Institute of Medical Genetics, Federal State Budgetary Scientific Institution “Tomsk National Research Medical Center of the Russian Academy of Sciences”

Email: maria.nazarenko@medgenetics.ru
Russian Federation, Tomsk

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Heat map reflecting the level of expression of CMP genes (tissue-specific expression patterns based on GTEx v6 RNA-seq8 data, analyzed using the FUMA GWAS resource [25]). Normalized expression level values ​​are shown.

Download (1MB)
3. Fig. 2. Biological processes and metabolic pathways enriched in CMP genes (visualization using Metascape [24]). Sources for enrichment assessment: GO – according to GO Biological Processes; WP - via WikiPathways; hsa – via KEGG Pathway.

Download (568KB)

Copyright (c) 2024 Russian Academy of Sciences

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies